In vitro and in vivo models for the study of oral delivery of nanoparticles
about
Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound DrugsA review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesLayer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine.Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injuryFormulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approachesMorphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer.Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations.Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices.Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems.The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.Recent advances in liposome surface modification for oral drug delivery.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin.Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel.Transport and uptake effects of marine complex lipid liposomes in small intestinal epithelial cell models.Gellan gum microspheres crosslinked with trivalent ion: effect of polymer and crosslinker concentrations on drug release and mucoadhesive properties.Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.Experimental Evaluation of the Transport Mechanisms of PoIFN-α in Caco-2 Cells.ZnO Interactions with Biomatrices: Effect of Particle Size on ZnO-Protein Corona.Sequentially dual-targeting vector with nano-in-micro structure for improved docetaxel oral delivery in vivo.Chitosan-ceramide coating on gold nanorod to improve its physiological stability and reduce the lipid surface-related toxicity.The effects of food components on the digestion of DNA by pepsin.Enhanced Intestinal Permeation of Doxorubicin Using Chitosan Nanoparticles
P2860
Q26741823-1CE6C411-C160-4E4C-A129-E8682D0789B2Q26744008-160DA3A5-5DC8-4A9A-A107-083B6F6C709DQ30874627-F21267AE-0231-47FB-8224-724505533787Q34088840-44204F43-4C16-4C7E-AF98-0E1D24F08E7BQ35706314-5613CE0C-4832-41B0-938D-1CEDFB75F2A9Q36106482-F32DBE04-3ADC-4F2B-A61F-1442C42F5F81Q36121396-B9FB7F29-4B8D-4342-8776-EED28D016FC2Q37265705-05F91C87-03EA-41E3-82D0-0C39512AF226Q37344258-023E7C84-DB62-40E9-AA11-15943C8956C6Q37684088-3353313B-F718-4CBF-A003-023E46D98349Q38239571-99075DEF-A841-4AB0-B9B7-C505331DADD4Q38550745-52EA3CBF-5353-4D15-B822-529CFA377D60Q38583850-F4F68339-506B-4926-B241-0D95AC994617Q38784932-33EBF0C6-08C9-41B4-9FEC-A9BD14DE56CFQ38807276-78A1F89B-86E2-4A95-B2C0-C836F5F2DBFAQ38831997-BBB77255-CBD7-4225-BDF0-0F9232FF9FD1Q38836879-7445D1C9-580E-4C9A-B7F2-566FEA36A966Q38862706-C6EC2D76-66AC-4F27-9833-20F7A8E521D3Q38894392-3B586EF0-0929-439C-84CA-C454E95727AAQ38995195-EBE7D74A-5510-479D-AF8A-EB06BFD68FD0Q39899962-3EA4CD39-4E55-4B96-846D-03A2AD033CCAQ40264397-4B00CE2D-2F13-4DB8-B6B7-78C35A25A316Q40728949-D3B32BA9-CFDE-475B-985F-C623A95B400BQ41168032-ED37C3B4-A778-4470-9458-A0E40C08CDF1Q46894151-8659537B-9E5D-4CFD-A751-1225FF3A3DB4Q47099252-E6B4E00B-1202-4E29-8DCE-7272F0731235Q51140394-F395B191-AAD0-4E61-948B-5FFA810BADD8Q51197751-86E57BB9-4E1E-4047-87F5-63D8946D2122Q51287377-80F0E9FA-DD76-443A-9835-878BBFB60A66Q57136235-27DF2DAD-2942-455A-8E64-768CE1871E7F
P2860
In vitro and in vivo models for the study of oral delivery of nanoparticles
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vitro and in vivo models for the study of oral delivery of nanoparticles
@ast
In vitro and in vivo models for the study of oral delivery of nanoparticles
@en
In vitro and in vivo models for the study of oral delivery of nanoparticles
@nl
type
label
In vitro and in vivo models for the study of oral delivery of nanoparticles
@ast
In vitro and in vivo models for the study of oral delivery of nanoparticles
@en
In vitro and in vivo models for the study of oral delivery of nanoparticles
@nl
prefLabel
In vitro and in vivo models for the study of oral delivery of nanoparticles
@ast
In vitro and in vivo models for the study of oral delivery of nanoparticles
@en
In vitro and in vivo models for the study of oral delivery of nanoparticles
@nl
P2860
P3181
P1476
In vitro and in vivo models for the study of oral delivery of nanoparticles
@en
P2093
Jennifer M. Gamboa
Kam W. Leong
P2860
P304
P3181
P356
10.1016/J.ADDR.2013.01.003
P407
P577
2013-06-15T00:00:00Z